Skip to Main Content

Author Details

Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
1987
258
52
PMIDPaper TitleJournal TitlePublished Year
37758847Diagnostic liquid biopsy biomarkers in renal cell cancer.Nat Rev Urol2024
36269935Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.J Clin Oncol2023
37545846Reliable Visualization of the Treatment Effect of Transperineal Focal Laser Ablation in Prostate Cancer Patients by Magnetic Resonance Imaging and Contrast-enhanced Ultrasound Imaging.Eur Urol Open Sci2023
37639648Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.J Clin Oncol2023
37419773Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement.Eur Urol2023
37267609Novel minimally invasive treatments for lower urinary tract symptoms: a systematic review and network meta-analysis.Int Braz J Urol2023
36918302Added Clinical Value of <sup>18</sup>F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy.Clin Genitourin Cancer2023
36441776A Multicenter, Randomized, Single-blind, 2-Arm Intervention Study Evaluating the Adverse Events and Quality of Life After Irreversible Electroporation for the Ablation of Localized Low-intermediate Risk Prostate Cancer.J Urol2023
34793840Advancements in the identification of EV derived mRNA biomarkers for liquid biopsy of clear cell renal cell carcinomas.Urology2022
35474600Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer.BJU Int2022
35577751Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation-A Multicenter Validation Study.Eur Urol Focus2022
35469702High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium.Eur Urol2022
35790459Image-guided <i>in-Vivo</i> Needle-Based Confocal Laser Endomicroscopy in the Prostate: Safety and Feasibility Study in 2 Patients.Technol Cancer Res Treat2022
35528785A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice.Eur Urol Open Sci2022
35528781Safety and Feasibility of Soractelite Transperineal Focal Laser Ablation for Prostate Cancer and Short-term Quality of Life Analysis from a Multicenter Pilot Study.Eur Urol Open Sci2022
35488115A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer.Sci Rep2022
35356754Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator.Ther Adv Urol2022
35934601Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).Eur Urol2022
35933242Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer.Eur Urol2022
35924207An optimized prostate biopsy strategy in patients with a unilateral lesion on prostate magnetic resonance imaging avoids unnecessary biopsies.Ther Adv Urol2022
35051385Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.Lancet Oncol2022
33185026Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID-19) pandemic: an international accelerated consensus statement.BJU Int2021
33618028Profiling the proteoforms of urinary prostate-specific antigen by capillary electrophoresis - mass spectrometry.J Proteomics2021
35008202Bladder-Sparing Chemoradiotherapy Combined with Immune Checkpoint Inhibition for Locally Advanced Urothelial Bladder Cancer-A Review.Cancers (Basel)2021
34331598Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro.Med Oncol2021
31401014Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting.Eur Urol Oncol2020
33489012Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium.J Extracell Vesicles2020
31753752EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort<sup>â¿ </sup>: Under the Auspices of the EAU-ESMO Guidelines Committees.Eur Urol2020
31961326Transperineal Laser Ablation Treatment for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction: Protocol for a Prospective In Vivo Pilot Study.JMIR Res Protoc2020
31866579The Feasibility and Utility of Cystoscopy-Guided Hydrogel Marker Placement in Patients With Muscle-Invasive Bladder Cancer.Pract Radiat Oncol2020
31718822Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials.Eur Urol2020
32508005The Successful Return-To-Work Questionnaire for Cancer Survivors (I-RTW_CS): Development, Validity and Reproducibility.Patient2020
32446863Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250].Eur Urol2020
32151466ECCO Essential Requirements for Quality Cancer Care: Prostate cancer.Crit Rev Oncol Hematol2020
32497056Detection of extracellular vesicles in plasma and urine of prostate cancer patients by flow cytometry and surface plasmon resonance imaging.PLoS One2020
32172294Extracellular vesicle isolation from human renal cancer tissue.Med Oncol2020
32463291BioXmark® liquid fiducial markers for image-guided radiotherapy in muscle invasive bladder cancer: a safety and performance trial.Br J Radiol2020
32483982The Diagnostic Yield and Concordance of Ureterorenoscopic Biopsies for Grading of Upper Tract Urothelial Carcinoma: A Dutch Nationwide Analysis.J Endourol2020
32315112Detection of clinically significant prostate cancer in biopsy-naïve men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsy.BJU Int2020
30033066Validation of Confocal Laser Endomicroscopy Features of Bladder Cancer: The Next Step Towards Real-time Histologic Grading.Eur Urol Focus2020
31549936The Role of Fluorescence In Situ Hybridization for Predicting Recurrence after Adjuvant bacillus Calmette-Guérin in Patients with Intermediate and High Risk Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data.J Urol2020
29102671Preliminary Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Focal Therapy with Irreversible Electroporation.Eur Urol Focus2019
31740927EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committeesâ¿ .Ann Oncol2019
29943219Ablation energies for focal treatment of prostate cancer.World J Urol2019
31443246Hyperthermia Treatment Planning Including Convective Flow in Cerebrospinal Fluid for Brain Tumour Hyperthermia Treatment Using a Novel Dedicated Paediatric Brain Applicator.Cancers (Basel)2019
31217820Numerical simulation modeling of the irreversible electroporation treatment zone for focal therapy of prostate cancer, correlation with whole-mount pathology and T2-weighted MRI sequences.Ther Adv Urol2019
30775246Metastatic prostate cancer remains incurable, why?Asian J Urol2019
30738098Recent advances in extracellular vesicle research for urological cancers: From technology to application.Biochim Biophys Acta Rev Cancer2019
31090088The First In Vivo Needle-Based Optical Coherence Tomography in Human Prostate: A Safety and Feasibility Study.Lasers Surg Med2019
30853064Nationwide treatment patterns and survival of older patients with prostate cancer.J Geriatr Oncol2019
  • 1 - 50 of 258

Recommended Authors

Giovanni Motterle
Mayo Clinic
Career Start Year 2017
Number of shared co-authors 19
Izak Faiena
Columbia University Medical Center
Career Start Year 2010
Number of shared co-authors 3
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 8
Michael A Liss
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 4
Adam Kinnaird
University of Alberta
Career Start Year 2007
Number of shared co-authors 6
Jonathan L Wright
University of Washington Medical Center
Career Start Year 2005
Number of shared co-authors 9
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 4
Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
Career Start Year 2004
Number of shared co-authors 45
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 3
Jun Hyuk Hong
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2002
Number of shared co-authors 1
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1999
Number of shared co-authors 8
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 11
Alan Thompson
The Royal Marsden NHS Foundation Trust
Career Start Year 1996
Number of shared co-authors 2
J??rn Kamradt
Clinic of Urology and Pediatric Urology, University of Saarland
Career Start Year 1996
Number of shared co-authors 0
Louis Lacombe
CHU de Quebec-Universite Laval
Career Start Year 1994
Number of shared co-authors 8
Douglas S Scherr
New York-Presbyterian Hospital
Career Start Year 1994
Number of shared co-authors 11
Choung-Soo Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1993
Number of shared co-authors 3
Chris Ogden
The Royal Marsden Hospital NHS Foundation Trust
Career Start Year 1993
Number of shared co-authors 2
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 4
Damien Bolton
University of Melbourne
Career Start Year 1988
Number of shared co-authors 8
Philip Cornford
Liverpool University Hospitals
Career Start Year 1988
Number of shared co-authors 9
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 25
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 11
Freddie C Hamdy
University of Oxford
Career Start Year 1987
Number of shared co-authors 19
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 44
Joseph L Chin
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 10
David E Neal
University of Oxford, John Radcliffe Hospital
Career Start Year 1981
Number of shared co-authors 11
Yves Fradet
CHU de Quebec-Universite Laval
Career Start Year 1975
Number of shared co-authors 16
Anthony J Costello
Royal Melbourne Hospital
Career Start Year 1974
Number of shared co-authors 10
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Career Start Year 1971
Number of shared co-authors 30

Collaborators

Laurence Collette
Belgium International Drug Development Institute
Co-authored papers 19
Michel Bolla
universite Grenoble-Alpes (UGA)
Co-authored papers 15
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 10
Hendrik Van Poppel
University Hospitals Leuven
Co-authored papers 8
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 7
Philippe Maingon
Pitie-Salpetriere Hospital, AP-HP.Sorbonne Universite
Co-authored papers 7
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 7
Michael L Steinberg
University of California los angeles
Co-authored papers 7
Amar U Kishan
University of California los angeles
Co-authored papers 7
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers 7
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 7
Inge M van Oort
Radboud University Medical Center
Co-authored papers 6
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 6
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 6
Tahmineh Romero
David Geffen School of Medicine at university of california los angeles
Co-authored papers 5
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers 5
Ting Martin Ma
University of Washington
Co-authored papers 5
Arnulf Stenzl
Eberhard Karls University of Tubingen
Co-authored papers 4
Araceli Guerrero
Hospital Son Espases
Co-authored papers 4
Alberto Briganti
IRCCS San Raffaele Scientific Institute
Co-authored papers 4
Peter Hoskin
Mount Vernon Cancer Centre
Co-authored papers 4
Almudena Zapatero
University Hospital La Princesa
Co-authored papers 4
Markus Graefen
University Hospital Frankfurt, Goethe University Frankfurt am Main
Co-authored papers 4
Baris Turkbey
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Xavier Maldonado
Hospital Universitari Vall d'Hebron
Co-authored papers 4
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Co-authored papers 3
Allison Steigler
University of Newcastle
Co-authored papers 3
Jeff M Michalski
Washington University School of Medicine
Co-authored papers 3
Mark Frydenberg
Monash University
Co-authored papers 3
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Co-authored papers 3
Release 1.2